ArticleOncotarget2016

The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.

Lorena P Suarez-Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.